Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 22Lymphoma, Large B-Cell, Diffuse 12Lymphoma 11Lymphoma, Non-Hodgkin 8Burkitt Lymphoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Recurrence 5Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Myelodysplastic Syndromes 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphocytic, Chronic, B-Cell 3Waldenstrom Macroglobulinemia 2Sarcoma, Myeloid 2Neoplasms 2Multiple Myeloma 2Leukemia, Hairy Cell 2Leukemia 2Hodgkin Disease 2HIV Infections 2Breast Neoplasms 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1

Interventions

Doxorubicin 4Dexrazoxane 3Methotrexate 2Cisplatin 2pegfilgrastim 1Vincristine 1Rituximab 1Razoxane 1Prednisolone 1Neoadjuvant Therapy 1Leucovorin 1Lenalidomide 1Ifosfamide 1Filgrastim 1Etoposide 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Captopril 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiotoxicity × Rituximab × Sarcoma × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡